InterventionsHumans

Weight Loss Maintenance following Semaglutide Discontinuation—The Role of Concurrent Lifestyle Intervention

ADA Scientific Sessions 2025 Abstract

The paper

Qiaochu Xue, Piaopiao Li, Elizabeth Staton,

Mohammed Kumail Ali, Rosette James Chakkalakal, K.M. Venkat Narayan, Young‐Rock Hong, Megha K Shah, Ping Zhang, Meda E. Pavkov, Lawrence S. Phillips,

Gainesville

ADA Scientific Sessions 2025 Abstract · 13 Jun 2025

Presented at ADA Scientific Sessions 2025 · Late-breaking 2199-LB

doi.org/10.2337/db25-2199-lb

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
Semaglutide may protect kidneys by reducing vascular resistance
Nature Medicine · 4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
The New England Journal of Medicine · 4 Oct 2026